Artículos Científicos

DATE: 2017/10/29
Who Receives Nalmefene and How Does It Work in the Real World? A Single-Arm, Phase IV Study of Nalmefene in Alcohol Dependent Outpatients: Baseline and 1-Month Results
Clin Drug Investig. 2018 Feb;38(2):147-155. doi: 10.1007/s40261-017-0590-4.
AUTHORS: Barrio P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A.
PMID: 29080208
DATE: 2017/05/12
Psychoactive constituents of cannabis and their clinical implications: a systematic review
Adicciones. 2018 Apr 15;30(2):140-151. doi: 10.20882/adicciones.858.
AUTHORS: Casajuana Köguel C, López-Pelayo H, Balcells-Olivero MM, Colom J, Gual A.
PMID: 28492950
DATE: 2017/02/08
Patients with alcohol use disorder: initial results from a prospective multicenter registry in the Spanish Network on Addiction Disorders. CohRTA Study
Adicciones. 2018 Jan 12;30(4):292-300. doi: 10.20882/adicciones.931.
AUTHORS: Sanvisens A, Zuluaga P, Rivas I, Rubio G, Gual A, Torrens M, Short A, Álvarez FJ, Tor J, Farré M, Rodríguez de Fonseca F, Muga R.
PMID: 28170055
DATE: 2016/10/18
Remediation therapy in patients with alcohol use disorders and neurocognitive disorders: A Pilot Study
Adicciones. 2018 Apr 15;30(2):93-100. doi: 10.20882/adicciones.757.
AUTHORS: Frías-Torres C, Moreno-España J, Ortega L, Barrio P, Gual A, Teixidor López L.
PMID: 27749971
DATE: 2016/10/18
Reduction of mortality following better detection of hypertension and alcohol problems in primary health care in Spain
Adicciones. 2018 Jan 1;30(1):9-18. doi: 10.20882/adicciones.726.
AUTHORS: Rehm J, Gmel G, Sierra C, Gual A.
PMID: 27749967
DATE: 2017/12/05
Scaling-up primary health care-based prevention and management of heavy drinking at the municipal level in middle-income countries in Latin America: Background and protocol for a three-country quasi-experimental study
F1000Res. 2017 Mar 23;6:311. doi: 10.12688/f1000research.11173.3. eCollection 2017.
AUTHORS: Anderson P, O’Donnell A, Kaner E, Gual A, Schulte B, Pérez Gómez A, de Vries H, Natera Rey G, Rehm J.
PMID: 29188013
DATE: 2017/10/13
Impact of practice, provider and patient characteristics on delivering screening and brief advice for heavy drinking in primary healthcare: Secondary analyses of data from the ODHIN five-country cluster randomized factorial trial
Eur J Gen Pract. 2017 Dec;23(1):241-245. doi: 10.1080/13814788.2017.1374365.
AUTHORS: Anderson P, Kłoda K, Kaner E, Reynolds J, Bendtsen P, Pelgrum-Keurhorst MN, Segura L, Wojnar M, Mierzecki A, Deluca P, Newbury-Birch D, Parkinson K, Okulicz-Kozaryn K, Drummond C, Laurant MGH, Gual A.
PMID: 29022763
DATE: 2017/09/29
Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union
BMC Med. 2017 Sep 28;15(1):173. doi: 10.1186/s12916-017-0934-1.
AUTHORS: Rehm J, Anderson P, Prieto JAA, Armstrong I, Aubin HJ, Bachmann M, Bastus NB, Brotons C, Burton R, Cardoso M, Colom J, Duprez D, Gmel G, Gual A, Kraus L, Kreutz R, Liira H, Manthey J, Møller L, Okruhlica Ľ, Roerecke M, Scafato E, Schulte B, Segura-Garcia L, Shield KD, Sierra C, Vyshinskiy K, Wojnar M, Zarco J.
PMID: 28954635
DATE: 2017/07/12
Delivery of Brief Interventions for Heavy Drinking in Primary Care: Outcomes of the ODHIN 5-Country Cluster Randomized Trial
Ann Fam Med. 2017 Jul;15(4):335-340. doi: 10.1370/afm.2051.
AUTHORS: Anderson P, Coulton S, Kaner E, Bendtsen P, Kłoda K, Reynolds J, Segura L, Wojnar M, Mierzecki A, Deluca P, Newbury-Birch D, Parkinson K, Okulicz-Kozaryn K, Drummond C, Gual A.
PMID: 28694269
DATE: 2017/06/25
Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: Prediction and impact on long-term survival
Hepatology. 2017 Dec;66(6):1842-1853. doi: 10.1002/hep.29338.
AUTHORS: Altamirano J, López-Pelayo H, Michelena J, Jones PD, Ortega L, Ginès P, Caballería J, Gual A, Bataller R, Lligoña A.
PMID: 28646515